Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma



McGowan, Daniel R, Skwarski, Michael, Bradley, Kevin M, Campo, Leticia, Fenwick, John D, Gleeson, Fergus V, Green, Marcus, Horne, Amanda, Maughan, Timothy S, McCole, Mark G
et al (show 12 more authors) (2019) Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma. EUROPEAN JOURNAL OF CANCER, 113. 87 - 95.

[img] Text
McGowan19.pdf - OA Published Version

Download (1MB) | Preview
Item Type: Article
Uncontrolled Keywords: Phase I trial, PI3K inhibitor, NSCLC, Radiotherapy, Tumour hypoxia, FMISO PET-CT
Depositing User: Symplectic Admin
Date Deposited: 13 Jun 2019 07:47
Last Modified: 02 Dec 2021 08:20
DOI: 10.1016/j.ejca.2019.03.015
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3045610